Komori
Mandarake (2652) · RiskRestated

Dependence on the Representative for Product Valuation

First written in FY2016. 5 of 8 entries say "Restated". Latest entry: FY2025.

8entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2018RestatedFY2022 – FY20252016: 12017: 120172018: 120182019: 020192020: 120202021: 120212022: 120222023: 020232024: 120242025: 12025
Same theme, other companies
Dependence on key executivesA theme 560 companies write about · 560 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 10 of 77 companies on the "Worse" side.

116 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 560 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「The company will divide among all its officers the duties that Furukawa Masuzo (古川益蔵) has developed over the years, drawing on their respective knowledge and experience, including that of Tanaka Mikinori (田中幹教), who became Representative Director and President, thereby reducing and ultimately eliminating this dependence.」

    To address dependence on the Representative Director and Chairman for product valuation, the company continues its policy of dividing responsibilities among all officers, including President Tanaka Mikinori (田中幹教), to reduce and ultimately eliminate this dependence.
  2. FY2024RestatedAnnual report

    「Across the company's operations, particularly in purchasing, it is highly dependent on its Representative Director and Chairman, Furukawa Masuzo (古川益蔵), when valuing highly rare and highly specialized items such as manuscripts, original artwork and shikishi boards. The company is transitioning to an operating structure that is not excessively dependent on the Representative Director and Chairman, but if the Representative Director and Chairman were to suffer an unforeseen incident at this time, business performance could be affected.」

    The company continues to describe its dependence on the Representative Director and Chairman for product valuation and its policy of transitioning to an operating structure that reduces and ultimately eliminates this dependence.
  3. FY2022RestatedAnnual report

    「The company will divide among all its officers the duties that Furukawa Masuzo (古川益蔵) has developed over the years, drawing on their respective knowledge and experience, including that of Tsujinaka Yujiro (辻中雄二郎), who became Representative Director, thereby reducing and ultimately eliminating this dependence.」

    To address dependence on the Chairman of the Board for product valuation, the company continues its policy of dividing responsibilities among all officers, including the Representative Director, to reduce and ultimately eliminate this dependence.
  4. FY2021ReframedAnnual report

    「Across the company's operations, particularly in purchasing, it is highly dependent on its Chairman of the Board, Furukawa Masuzo (古川益蔵), when valuing highly rare and highly specialized items such as manuscripts, original artwork and shikishi boards. The company is transitioning to an operating structure that is not excessively dependent on the Chairman of the Board, but if the Chairman of the Board were to suffer an unforeseen incident at this time, business performance could be affected.」

    The risk previously described as dependence on the Representative Director is now described, following the change of Representative Director and President, as dependence on the Chairman of the Board. The policy of reducing and ultimately eliminating this dependence continues.
  5. FY2020MitigatedAnnual report

    「The company will divide among all its officers the duties that Furukawa Masuzo (古川益蔵) has developed over the years, drawing on their respective knowledge and experience, including that of the newly appointed Representative Director, Tsujinaka Yujiro (辻中雄二郎), thereby reducing and eventually eliminating this dependence.」

    To address the risk of dependence on its representative, the company has specified a policy of dividing responsibilities among all officers, including the new President, to reduce and ultimately eliminate this dependence.
  6. FY2018RestatedAnnual report

    「Across the company's operations, particularly in purchasing, it is highly dependent on its Representative Director, Furukawa Masuzo (古川益蔵), when valuing highly rare and highly specialized items such as manuscripts, original artwork and shikishi boards. The company aims to transition to an operating structure that is not excessively dependent on its representative, but if the representative were to leave the company or suffer an unforeseen incident at this time, business performance could be affected.」

    The company continues to describe its dependence on the representative for product valuation and its policy of transitioning to an operating structure that reduces and ultimately eliminates this dependence.
  7. FY2017RestatedAnnual report

    「The company aims to transition to an operating structure that is not excessively dependent on its representative. However, if the representative were to leave the company or suffer an unforeseen incident at this time, business performance could be affected.」

    While stating its policy of transitioning away from excessive dependence on its representative, the company continues to describe its current dependence and the associated risk to business performance.
  8. FY2016First statedAnnual report

    「Across the company's operations, particularly in purchasing, it is highly dependent on its Representative Director, Furukawa Masuzo (古川益蔵), when valuing highly rare and highly specialized items such as manuscripts, original artwork and shikishi boards.」

    The company identifies its dependence on the Representative Director for valuing rare and specialized products as a risk that may affect business performance in the event of his departure or an unforeseen incident.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Mandarake yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Dependence on the Representative for Product Valuation | MANDARAKE INC. (2652) | Komori